6092 — Enbio Holdings Income Statement

0.000.00%

Last trade - 00:00

IndustrialsAdventurousMicro CapContrarian

Annual income statement for Enbio Holdings, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	JAS	JAS	JAS	JAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	7,408	6,841	8,988	8,120	9,576
Cost of Revenue
Gross Profit	2,088	1,890	2,426	2,764	2,484
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	7,032	6,339	7,855	6,873	8,762
Operating Profit	376	502	1,133	1,247	813
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	834	488	1,099	1,233	1,066
Provision for Income Taxes
Net Income After Taxes	532	331	707	795	740
Minority Interest
Net Income Before Extraordinary Items
Net Income	555	304	654	812	709
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	555	304	654	812	709
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	54.8	57.6	109	134	90
Dividends per Share